Citation Impact
Citing Papers
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics
2021 Standout
The role of fragile X mental retardation protein in major mental disorders
2010
Discovery of heterobicyclic templates for novel metabotropic glutamate receptor subtype 5 antagonists
2007
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
2018
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Microglial immune checkpoint mechanisms
2018
Microglial regional heterogeneity and its role in the brain
2019
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase
2013
The modified Geller–Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation
2009
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
2009
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
2007 Standout
Psychedelics
2016 Standout
Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats
2009
Allosteric Modulation of Family C G-Protein-Coupled Receptors: from Molecular Insights to Therapeutic Perspectives
2011
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Molecular Dynamics Simulation for All
2018 Standout
An appetitively conditioned taste elicits a preferential increase in mesolimbic dopamine release
1994
Severe Sepsis and Septic Shock
2013 Standout
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
2011 Standout
Interaction between microbiota and immunity in health and disease
2020 Standout
Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent
2007
What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis
2017 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
2014
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agents
2008
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor
2010 StandoutNatureNobel
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut–Brain Axis
2020
Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease
2011
Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants
2008
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner
2012 Standout
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
2003
Novelty and Anxiolytic Drugs Dissociate Two Components of Hippocampal Theta in Behaving Rats
2013 StandoutNobel
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders
2008
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
The Universal Field Hypothesis of Catatonia and Neuroleptic Malignant Syndrome
2000
The age of anxiety: role of animal models of anxiolytic action in drug discovery
2011
Glutamatergic (N-Methyl-d-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?
2009
The structure and function of G-protein-coupled receptors
2009 StandoutNatureNobel
DNA Methylation and Its Basic Function
2012 Standout
Activation of Orexin 1 Receptors in the Periaqueductal Gray of Male Rats Leads to Antinociception via Retrograde Endocannabinoid (2-Arachidonoylglycerol)-Induced Disinhibition
2011
How were new medicines discovered?
2011 Standout
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior
2010 StandoutNobel
The Central Nervous System and the Gut Microbiome
2016
The Role of Glutamate in Anxiety and Related Disorders
2005
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Role of the Nucleus Accumbens and the Striatum in the Production of Turning Behaviour in Intact Rats
1994
Drug development for CNS disorders: strategies for balancing risk and reducing attrition
2007
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
2012
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment
2003
Microglia turnover with aging and in an Alzheimer's model via long-term in vivo single-cell imaging
2017
The Pathophysiological Role of Microglia in Dynamic Surveillance, Phagocytosis and Structural Remodeling of the Developing CNS
2017
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
Recent advances in Sonogashira reactions
2011 Standout
The use of antiviral agents for the management of severe influenza
2010
Development of allosteric modulators of GPCRs for treatment of CNS disorders
2013
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Discovery of Molecular Switches That Modulate Modes of Metabotropic Glutamate Receptor Subtype 5 (mGlu5) Pharmacology in Vitro and in Vivo within a Series of Functionalized, Regioisomeric 2- and 5-(Phenylethynyl)pyrimidines
2009
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition
2016
Molecular Docking and Structure-Based Drug Design Strategies
2015 Standout
Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
1998
Palladium-Catalyzed Suzuki−Miyaura Cross-Coupling Reactions Employing Dialkylbiaryl Phosphine Ligands
2008 Standout
Molecular Docking: Shifting Paradigms in Drug Discovery
2019 Standout
Evaluation of Amides, Carbamates, Sulfonamides, and Ureas of 4-Prop-2-ynylidenecycloalkylamine as Potent, Selective, and Bioavailable Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5
2019
Neuraminidase inhibitors for preventing and treating influenza in adults and children
2014
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
2013
Serotonin Receptors
2008
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Diabetic Somatic Neuropathies
2004 Standout
Microglial M1/M2 polarization and metabolic states
2015 Standout
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
2006
Dopamine Receptors: From Structure to Function
1998 Standout
Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5
2010
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Eric Prinssen being referenced
The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties
1998
5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy
2002
Maternal immune activation and abnormal brain development across CNS disorders
2014
Involvement of the nucleus accumbens in oral behaviour in the freely moving rat
1993
Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats
2007
The Role of Serotonin Receptor Subtypes in the Behavioural Effects of Neuroleptic Drugs. A Paw Test Study in Rats
1994
A combined marble burying–locomotor activity test in mice: A practical screening test with sensitivity to different classes of anxiolytics and antidepressants
2006
The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison
2005
Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices
2010
Jaw muscle activity, the nucleus accumbens and dopaminergic agonists: A new approach
1992
Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir
2008
Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity
2005
Combined antagonism of adrenoceptors and dopamine and 5-HT receptors underlies the atypical profile of clozapine
1994
CTEP: A Novel, Potent, Long-Acting, and Orally Bioavailable Metabotropic Glutamate Receptor 5 Inhibitor
2011
Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists
2006